As China embarks on its three-year "weight management" campaign, Novo Nordisk has stepped forward with its powerful tools to ...

With official shortages ended, but the first generics gearing up for launch, companies are looking for the next generation of ...

Eli Lilly launched its blockbuster diabetes and weight-loss drug Mounjaro in India on Thursday, beating rival Novo Nordisk ...

Until two years ago, such discussion was of little practical relevance since there were few treatments for obesity between ...

Taylor McDaniels started taking medication to help her lose weight, but it's led to changes to many of her habits, including how she cooks at home and her budget.

Russia has a new business elite and radically altered marketplace—and it’s done away with key legal protections.

Novo Nordisk's GLP-1 receptor agonist semaglutide has shown efficacy as a treatment for metabolic dysfunction-associated steatohepatitis (MASH) in a phase 3 trial, potentially teeing up US and ...